In a small subset of samples, double immunostainings for IDO1 and CD3 were performed, revealing a significantly higher proportion of intratumoural CD3+ cells in IDO1-low expressing tumours as compared with IDO1-high expressing tissue samples. Here, IDO1 is linked to neoplasm.